Bosutris 400 Tablet
By Bosutris
Rx
30 Tablet in a Bottle

Composition
Bosutinib(400mg)

Manufacturer - Mylan Pharmaceuticals Pvt Ltd
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103

Expires on or after
August, 2025
About Bosutris 400 Tablet
Bosutris 400 Tablet is a powerful anti-cancer medication primarily used for treating chronic myeloid leukemia, a type of blood cancer. This medicine is specifically designed to slow down the multiplication and growth of cancer cells, therefore aiding in inhibiting the progression of the disease in the body. It is crucial to strictly follow your doctor's instructions regarding the dosage and duration of the medication. You can take Bosutris 400 Tablet with or without food, but it is important to take it consistently at the same time each day to help you remember.
Common side effects of Bosutris 400 Tablet may include respiratory tract infections, low blood platelet levels, decreased white blood cells, anemia, headaches, breathing difficulties, cough, changes in liver enzyme levels, diarrhea, vomiting, nausea, and abdominal pain. If you experience any of these side effects, it is essential to inform your doctor promptly. They may suggest ways to manage or prevent these side effects. Furthermore, immediate medical attention is necessary if you encounter severe headaches, swelling in one leg, breathing difficulties, or changes in vision or hearing.
Before starting treatment with Bosutris 400 Tablet, inform your doctor about any preexisting medical conditions you have. It is crucial to disclose all other medications you are currently taking to avoid potential interactions. Pregnant and breastfeeding women should not use this medication as it may pose risks to the developing baby. Additionally, Bosutris 400 Tablet should be avoided by individuals allergic to its components and those with specific medical conditions like liver or kidney disease, gastrointestinal issues, myelosuppression, fluid retention, and hepatic toxicity.
Overall, Bosutris 400 Tablet plays a vital role in targeting and inhibiting abnormal proteins that lead to the multiplication of cancerous cells, thereby helping to prevent the further spread of cancer in the body. Adhering to your doctor's guidance, monitoring for side effects, and maintaining open communication with your healthcare provider are key aspects of safely and effectively using Bosutris 400 Tablet in the treatment of chronic myeloid leukemia.
Benefits
Bosutris 400 Tablet, containing Bosutinib, which is a kinase inhibitor, offers significant benefits in treating blood cancer, specifically Chronic Myeloid Leukaemia. This type of cancer, affecting white blood cells, can weaken the body's immune system's ability to fight infections. The medication works by targeting and killing cancer cells while also preventing their growth and multiplication. By inhibiting the action of abnormal proteins responsible for the rapid division of cancerous cells, Bosutris 400 Tablet effectively halts the abnormal growth of cancer cells. This action contributes to reducing the spread of cancer to other parts of the body. It is important to note that during the course of treatment with Bosutris 400 Tablet, individuals should refrain from consuming alcohol and ensure adequate hydration by drinking plenty of water.
How to use the Bosutris 400 Tablet
To use Bosutris 400 Tablet, follow your doctor's instructions carefully. Take the medicine in the dose and duration recommended by your doctor. Swallow the tablet whole with a glass of water. Avoid chewing, crushing, or breaking the tablet. You can take Bosutris 400 Tablet with or without food, but it is advisable to take it at the same time each day for consistency. Remember not to exceed the prescribed dosage. If you have any questions or concerns about how to use Bosutris 400 Tablet, consult your doctor for further guidance.
Uses of Bosutris 400 Tablet
Bosutris 400 Tablet is commonly used to treat a type of blood cancer known as Philadelphia chromosome-positive chronic myeloid leukemia (CML). This medication is specifically designed to target and manage this particular form of leukemia. By specifically addressing the Philadelphia chromosome-positive aspect of CML, Bosutris 400 Tablet helps in the treatment and control of this type of blood cancer.
What conditions Bosutris 400 Tablet treats?
Bosutris 400 Tablet is used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia. This type of leukemia, which is a form of blood cancer, results in the overproduction of immature white blood cells in the bone marrow. This leads to a weakened immune system, making it difficult for the body to fight infections. Ph+ chronic myeloid leukemia is characterized by a specific chromosome abnormality known as the Philadelphia chromosome, which triggers the production of abnormal white blood cells. Symptoms of this condition may include fatigue, fever, weight loss, and loss of appetite.
Should you consult a doctor?
If you experience severe headaches, swelling in one leg, pain while breathing, changes in vision, or hearing changes while taking Bosutris 400 Tablet, it is important to seek immediate medical attention. Additionally, if you notice persistent side effects such as abdominal pain, nausea, vomiting, diarrhea, headache, cough, low blood platelets, anemia, nasopharyngitis, respiratory tract infection, decreased white blood cell count, breathlessness, or increased liver enzymes, consult your doctor. It is essential to inform your healthcare provider about any bothersome symptoms so they can provide guidance on managing or preventing them. Prior to starting Bosutris 400 Tablet, discuss your preexisting medical conditions and current medications with your doctor. Pregnant and breastfeeding women should avoid taking this medication due to potential harm to the developing baby. Remember to take Bosutris 400 Tablet as prescribed by your doctor, without suddenly stopping the treatment, to ensure its effectiveness in managing chronic myeloid leukemia.
Side effects of Bosutris 400 Tablet
When taking Bosutris 400 Tablet, some common side effects may occur. These side effects can include abdominal pain, nausea, vomiting, and diarrhea. You may also experience a headache, cough, and respiratory tract infections. Other side effects could involve low blood platelets, resulting in symptoms like anemia or increased risk of bleeding. In some cases, you might encounter a decrease in white blood cell count, specifically neutrophils, which can affect your immune system. Breathlessness may also occur, alongside elevated liver enzymes. Additional side effects may manifest as nausea, diarrhea, painful urination, decreased platelet count, fatigue, edema, back pain, dizziness, and skin rash. It is essential to note that most of these side effects do not necessarily need medical attention as they may resolve as your body gets used to the medication. However, if these side effects persist or cause concern, it is advised to consult your doctor promptly.
Safety advice

liver
When using Bosutris 400 Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment for this medication. To ensure the safe and effective use of Bosutris 400 Tablet, it is advised to consult your doctor regarding any liver-related concerns before starting the treatment.

kidney
Bosutris 400 Tablet requires caution in patients with kidney disease. Adjustments in dosage may be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Bosutris 400 Tablet.

driving
It is not clear if Bosutris 400 Tablet affects driving skills. Avoid driving if you have symptoms that impact your focus or reaction time.

pregnancy
Bosutris 400 Tablet is considered unsafe during pregnancy due to potential risks to the developing baby. However, in rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor before use.

breastfeeding
Caution must be taken while breastfeeding if considering Bosutris 400 Tablet. Limited data suggests potential harm to the baby through breastmilk transmission.
Consumption warning before consuming Bosutris 400 Tablet
Before consuming Bosutris 400 Tablet, it is crucial to note certain precautions. Do not take this medication if you have allergies to it or any of its components. Inform your doctor about your medical history, current medications, and any conditions like liver or kidney disease, diabetes, cardiac issues, high blood pressure, gastrointestinal problems, myelosuppression, fluid retention, or hepatic toxicity. Bosutris 400 Tablet can have serious side effects in individuals with these conditions. It is also important to discuss pregnancy or plans for pregnancy with your doctor, as this medicine can harm the fetus. Breastfeeding should be stopped during treatment. This tablet is not recommended for individuals under 18 years. Additionally, avoid alcohol and smoking as they can worsen the effects of Bosutris 400 Tablet.
Disease interactions
Before taking Bosutris 400 Tablet, it is important to inform your doctor about any existing kidney or liver disease, gastrointestinal disorders, diabetes, hepatotoxicity, and cardiac disorders. These conditions can potentially interact with Bosutris 400 Tablet and may impact its effectiveness or cause adverse effects. It is crucial for your doctor to be aware of your medical history to ensure the safe use of this medication and to prevent any potential complications. Please disclose all relevant information about your health to your healthcare provider before starting treatment with Bosutris 400 Tablet.
What if you forgot to take Bosutris 400 Tablet?
If you forget to take a dose of Bosutris 400 Tablet, simply skip that missed dose and carry on with your regular dosing schedule. It is important not to take a double dose to make up for the missed one. Just take the next dose at the usual time and continue with your treatment plan as prescribed by your healthcare provider. Taking extra doses can increase the risk of experiencing unwanted side effects. If you have any concerns about missed doses or how to manage your medication schedule, consult your healthcare professional for guidance.
Related lab tests
Related Lab Tests for Bosutris 400 Tablet include Bcr-Abl Gene Translocation tests, which can be done qualitatively or quantitatively to check for specific genetic abnormalities. These tests help in monitoring the response to treatment and disease progression. Another important test is the Complete Blood Count, which provides information about different blood cells like red blood cells, white blood cells, and platelets. This test helps in assessing overall health and detecting any abnormalities. The Peripheral Smear Examination is also recommended as it involves examining a drop of blood under a microscope to assess the shape and size of blood cells. These tests are crucial in evaluating the effectiveness of Bosutris 400 Tablet treatment and monitoring any potential side effects.
Additional Information
Habit Forming | No |
Chemical Class | 4-aminoquinolines |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹8900
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025